Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Willenborg

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Immunology and Cell Biology|September 21, 2001
Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytesE J Hindmarsh, M A Staykova, D O Willenborg, et al.
Acta Neurologica Scandinavica|March 1, 1992
Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibitionR D Simmons, A R Hugh, D O Willenborg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitisD O Willenborg, S Fordham, C C Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxideD O Willenborg, S A Fordham, M A Staykova, et al.
The Journal of Experimental Medicine|July 1, 1992
Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cellsJ D MacMicking, D O Willenborg, M J Weidemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitisS R McColl, M A Staykova, A Wozniak, et al.
Journal of Neuroimmunology|November 1, 1993
Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged ratsP A Ludowyk, W Hughes, A Hugh, et al.
Immunology and Cell Biology|August 1, 1997
DNA vaccines for the treatment of autoimmune diseaseI A Ramshaw, S A Fordham, C C Bernard, et al.
Immunology and Cell Biology|April 29, 1998
Treatment of central nervous system inflammation with inhibitors of basement membrane degradationC R Parish, E J Hindmarsh, M R Bartlett, et al.
Journal of Neuroscience Research|August 1, 1995
Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approachC J Xian, R D Simmons, D O Willenborg, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Immunology and Cell Biology|September 21, 2001
Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytesE J Hindmarsh, M A Staykova, D O Willenborg, et al.
Acta Neurologica Scandinavica|March 1, 1992
Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibitionR D Simmons, A R Hugh, D O Willenborg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitisD O Willenborg, S Fordham, C C Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxideD O Willenborg, S A Fordham, M A Staykova, et al.
The Journal of Experimental Medicine|July 1, 1992
Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cellsJ D MacMicking, D O Willenborg, M J Weidemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitisS R McColl, M A Staykova, A Wozniak, et al.
Journal of Neuroimmunology|November 1, 1993
Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged ratsP A Ludowyk, W Hughes, A Hugh, et al.
Immunology and Cell Biology|August 1, 1997
DNA vaccines for the treatment of autoimmune diseaseI A Ramshaw, S A Fordham, C C Bernard, et al.
Immunology and Cell Biology|April 29, 1998
Treatment of central nervous system inflammation with inhibitors of basement membrane degradationC R Parish, E J Hindmarsh, M R Bartlett, et al.
Journal of Neuroscience Research|August 1, 1995
Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approachC J Xian, R D Simmons, D O Willenborg, et al.
Pageof 6